We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VERASEAL (Grifols Australia Pty Ltd)
Product name
VERASEAL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
206 (255 working days)
Active ingredients
Fibrinogen, human thrombin
Registration type
EOI
Indication
VeraSeal is used as supportive treatment in children where standard surgical techniques are insufficient for improvement of hemostasis
VeraSeal is indicated in children and adults where standard surgical techniques are insufficient for suture support: in vascular surgery.